Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125058292 | 12505829 | 2 | F | 20160620 | 20160628 | 20160708 | EXP | US-ASTRAZENECA-2016SE51382 | ASTRAZENECA | 0.00 | M | Y | 0.00000 | 20160709 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125058292 | 12505829 | 1 | PS | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | U | U | 21153 | |||||||||
| 125058292 | 12505829 | 2 | SS | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | U | U | 21153 | |||||||||
| 125058292 | 12505829 | 3 | SS | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | U | U | 21153 | |||||||||
| 125058292 | 12505829 | 4 | SS | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | U | U | 21153 | |||||||||
| 125058292 | 12505829 | 5 | SS | PRILOSEC | OMEPRAZOLE MAGNESIUM | 1 | Oral | U | U | 0 | MODIFIED-RELEASE TABLET | ||||||||
| 125058292 | 12505829 | 6 | SS | NEXIUM 24HR | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | U | 0 | ||||||||||
| 125058292 | 12505829 | 7 | SS | PRILOSEC OTC | OMEPRAZOLE MAGNESIUM | 1 | Oral | U | 0 | MODIFIED-RELEASE TABLET | |||||||||
| 125058292 | 12505829 | 8 | SS | PREVACID | LANSOPRAZOLE | 1 | Unknown | U | U | 0 | |||||||||
| 125058292 | 12505829 | 9 | SS | PREVACID | LANSOPRAZOLE | 1 | Unknown | U | U | 0 | |||||||||
| 125058292 | 12505829 | 10 | SS | PREVACID | LANSOPRAZOLE | 1 | Unknown | U | U | 0 | |||||||||
| 125058292 | 12505829 | 11 | SS | PREVACID | LANSOPRAZOLE | 1 | Unknown | U | U | 0 | |||||||||
| 125058292 | 12505829 | 12 | SS | KAPIDEX | DEXLANSOPRAZOLE | 1 | Unknown | U | U | 0 | |||||||||
| 125058292 | 12505829 | 13 | SS | ACIPHEX | RABEPRAZOLE SODIUM | 1 | Unknown | U | U | 0 | |||||||||
| 125058292 | 12505829 | 14 | SS | PROTONIX | PANTOPRAZOLE SODIUM | 1 | Unknown | U | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125058292 | 12505829 | 1 | Dyspepsia |
| 125058292 | 12505829 | 2 | Gastrooesophageal reflux disease |
| 125058292 | 12505829 | 3 | Peptic ulcer |
| 125058292 | 12505829 | 4 | Gastric disorder |
| 125058292 | 12505829 | 5 | Dyspepsia |
| 125058292 | 12505829 | 8 | Dyspepsia |
| 125058292 | 12505829 | 9 | Gastrooesophageal reflux disease |
| 125058292 | 12505829 | 10 | Peptic ulcer |
| 125058292 | 12505829 | 11 | Gastric disorder |
| 125058292 | 12505829 | 12 | Dyspepsia |
| 125058292 | 12505829 | 13 | Dyspepsia |
| 125058292 | 12505829 | 14 | Dyspepsia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125058292 | 12505829 | OT |
| 125058292 | 12505829 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125058292 | 12505829 | Acute kidney injury | |
| 125058292 | 12505829 | Chronic kidney disease | |
| 125058292 | 12505829 | Renal failure | |
| 125058292 | 12505829 | Tubulointerstitial nephritis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125058292 | 12505829 | 1 | 200610 | 201604 | 0 | |
| 125058292 | 12505829 | 2 | 200610 | 201604 | 0 | |
| 125058292 | 12505829 | 3 | 200610 | 201604 | 0 | |
| 125058292 | 12505829 | 4 | 200610 | 201604 | 0 |